8-K - Rhythm Pharmaceuticals, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Rhythm Pharmaceuticals elected Kimberly J. Popovits as a non-employee Class II director and accepted Edward T. Mathers' resignation from the Board, both effective April 1, 2026.

Key Takeaways

1Board elected Kimberly J. Popovits as non-employee Class II director effective April 1, 2026, to serve until 2028 annual meeting.

2Edward T. Mathers resigned from Board effective April 1, 2026, with no disagreements on company operations, policies or practices.

3Popovits compensated per non-employee director policy filed as Exhibit 10.6 to 2025 10-K.

4Popovits and Company to enter standard indemnification agreement filed as Exhibit 10.1 to 2025 10-K.

5Press release issued April 3, 2026, announcing board changes (Exhibit 99.1).

Current Report Details

Event Type

Management Change

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers On April

Management Change

Company or the Board on any matter relating to the Company

7.01

of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Ac

Regulation Fd

9.01

. Financial Statements and Exhibits (d) Exhibits The following Exhibit 99.1 shall be deemed to be furnished and not filed. Exhibit No.: 99.1 | Description: Pres

Exhibits Only

Source Document

Executive & Director Changes

Kimberly J. Popovits

non-employee director (Class II)

elected

Effective: 2026-04-01

Edward T. Mathers

director

resigned

Effective: 2026-04-01

not caused by any disagreement with the Company or the Board on any matter relating to the Company’s operations, policies or practices

Exhibits (2)

8-K

99.1

EX-99.1